Gene Therapy Market Size, Share, and Analysis, By Type (Gene Silencing, Gene Augmentation, Cell Replacement, Other Therapies), By Vector (Viral Vectors, Non-Viral Vectors), By Therapeutic Area (Neurology, Oncology, Hepatology, Other Therapeutic Areas), By

Gene Therapy Market Size, Share, and Analysis, By Type (Gene Silencing, Gene Augmentation, Cell Replacement, Other Therapies), By Vector (Viral Vectors, Non-Viral Vectors), By Therapeutic Area (Neurology, Oncology, Hepatology, Other Therapeutic Areas), By Delivery Method (In Vivo, Ex Vivo), By Route of Administration (Intravenous, Other Routes of Administration) and By Region (North America, Europe, Asia-Pacific, And Rest of the World) And Regional Forecast 2024-2034

PRODUCT OVERVIEW

Gene Therapy Market is anticipated to grow at a CAGR of 20.4% in the forecast period (2024-2034), with the market size valued at USD 8.6 billion in 2023 and projected to reach USD 66.8 billion by 2034.

Gene therapy is a revolutionary medical technique aimed at treating or curing genetic disorders by modifying the genetic material within a patient's cells. This approach involves the addition, removal, or alteration of genetic material to correct defective genes responsible for disease. There are two main types of gene therapy: in vivo (delivered directly into the patient's body) and ex vivo (where cells are genetically modified outside the body and then reintroduced). Gene therapy holds promise for treating various conditions, including genetic disorders, certain cancers, and viral infections. Despite its potential, challenges such as high costs, technical difficulties, and ethical concerns continue to influence the development and application of gene therapy.

MARKET HIGHLIGHTS

The Gene Therapy Market is projected to grow at a compound annual growth rate (CAGR) of 20.4% from 2024 to 2034, reaching an estimated value of USD 66.8 billion. This growth is driven by advances in genetic engineering technologies like CRISPR and viral vector technologies, which enhance the precision and efficacy of gene therapies. The increasing prevalence of genetic disorders and the demand for targeted therapies are boosting interest in the market. Significant investments in research and development from both public and private sectors are driving innovation and expanding the pipeline of gene therapy treatments. Regulatory approvals and supportive policies further propel market growth. The future of gene therapy looks promising with its increasing application in treating cancer and rare diseases, improvements in delivery methods, and potential reduction in treatment costs, all contributing to the market's expansion and progress in personalized medicine.

Gene Therapy Market Segments:

• By Type
• Gene Silencing
• Gene Augmentation
• Cell Replacement
• Other Therapies
• By Vector
• Viral Vectors
• Non-Viral Vectors
• By Therapeutic Area
• Neurology
• Oncology
• Hepatology
• Other Therapeutic Areas
• By Delivery Method
• In Vivo
• Ex Vivo
• By Route of Administration
• Intravenous
• Other Routes of Administration

MARKET DYNAMICS

Growth Drivers

Advancements in Gene Editing Technologies to Provide Market Growth and Expansion Opportunities

Increased Regulatory Approvals for Gene Therapies is Expanding Market Access

Restraint

Manufacturing Complexities Can Hinder Growth and Development Opportunities

Key Players

• Novartis
• Spark Therapeutics
• Regenxbio
• Gilead Sciences
• CRISPR Therapeutics
• Vertex Pharmaceuticals
• Pfizer
• Bluebird Bio
• Bayer AG
• AstraZeneca
• Sangamo Therapeutics
• Merck KGaA
• Astellas Pharma
• Takeda Pharmaceutical
• BioMarin Pharmaceutical
• Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:

• North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
• Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
• Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
• Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
• Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 3-month post-sales analyst support.

*Please Note: The report will be delivered in 2-3 business days upon order confirmation*